首页> 外文期刊>Seminars in Respiratory and Critical Care Medicine >Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease
【24h】

Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease

机译:急性呼吸衰竭和终末期肝病的肺部并发症

获取原文
获取原文并翻译 | 示例
           

摘要

Acute respiratory failure has a high mortality in patients with end-stage liver disease (ESLD). These patients may develop acute respiratory failure for reasons specific to advanced liver disease, including hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. They may also develop respiratory complications due to conditions seen in the general intensive care unit population to which ESLD patients are at higher risk, including infection, volume overload, and the acute respiratory distress syndrome. Management of these patients is complicated and multifaceted, and a comprehensive understanding of the etiologies and treatment of acute respiratory failure is critical in this high-risk patient population. This article reviews current evidence surrounding the prevalence, management, and complications of the various etiologies of acute respiratory failure in ESLD patients.
机译:急性呼吸衰竭具有高患者患者肝病(ESLD)的患者。 这些患者可能会出现急性呼吸衰竭,原因是先进的肝病,包括肝综合征,Portopulary高血压和肝湿疏水素。 由于ESLD患者的风险更高,包括感染,容量过载和急性呼吸窘迫综合征,因此它们也可能产生由于在一般密集的护理单元人口中看到的病症而产生呼吸并发症。 这些患者的管理是复杂和多方面的,综合了解急性呼吸衰竭的病因和治疗在这种高危患者人群中至关重要。 本文审查了当前证据存在普遍呼吸衰竭在ESLD患者的患病率,管理和并发症的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号